CTOs on the Move

Defense Health Agency

www.health.mildha

 
The DHA is a joint, integrated Combat Support Agency that enables the Army, Navy, and Air Force medical services to provide a medically ready force and ready medical force to Combatant Commands in both peacetime and wartime. The DHA supports the delivery of integrated, affordable, and high quality health services to 9.5 million Military Health System beneficiaries and is responsible for driving greater integration of clinical and business processes across the MHS. The DHA oversees the delivery of health care services like the TRICARE Health Plan, pharmacy, public health, and health information technology. DHA carries out these operations using a ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.health.mildha
  • 7700 Arlington Boulevard Suite 5101
    Falls Church, VA USA 22042
  • Phone: 888.647.6676

Executives

Name Title Contact Details
Lisa Belter
Chief Technology Officer Profile

Similar Companies

Betz Mitchell Associates

Betz Mitchell Associates is a Westbury, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The CE Solution

The CE Solution is a Syosset, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

sbifinechemicals

sbifinechemicals is a EDMONTON, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BreezoMeter

BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.